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Abstract
Anorexia nervosa (AN) is a psychiatric disease with devastating physical consequences, with
a pathophysiological mechanism still to be elucidated. Metagenomic studies on anorexia ner-
vosa have revealed profound gut microbiome perturbations as a possible environmental fac-
tor involved in the disease. In this study we performed a comprehensive analysis integrating
data on gut microbiota with clinical, anthropometric and psychological traits to gain new
insight in the pathophysiology of AN. Fifteen AN women were compared with fifteen age-,
sex- and ethnicity-matched healthy controls. AN diet was characterized by a significant lower
energy intake, but macronutrient analysis highlighted a restriction only in fats and carbohy-
drates consumption. Next generation sequencing showed that AN intestinal microbiota was
significantly affected at every taxonomic level, showing a significant increase of Enterobac-
teriaceae, and of the archeon Methanobrevibacter smithii compared with healthy controls.
On the contrary, the genera Roseburia, Ruminococcus and Clostridium, were depleted, in
line with the observed reduction in AN of total short chain fatty acids, butyrate, and propio-
nate. Butyrate concentrations inversely correlated with anxiety levels, whereas propionate
directly correlated with insulin levels and with the relative abundance of Roseburia inulinivor-
ans, a known propionate producer. BMI represented the best predictive value for gut dysbio-
sis and metabolic alterations, showing a negative correlation with Bacteroides uniformis
(microbiota), with alanine aminotransferase (liver function), and with psychopathological
scores (obsession-compulsion, anxiety, and depression), and a positive correlation with
white blood cells count. In conclusion, our findings corroborate the hypothesis that the gut
dysbiosis could take part in the AN neurobiology, in particular in sustaining the persistence of
alterations that eventually result in relapses after renourishment and psychological therapy,
but causality still needs to be proven.
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Introduction
Eating disorders are an important cause of physical and psychosocial morbidity in adolescent
girls and adult women [1]. Anorexia nervosa (AN) is a life threatening mental illness charac-
terized by extreme energy intake restriction that leads to dangerous low body weight, associ-
ated with gastrointestinal, cardiovascular, immunological diseases and metabolic
abnormalities [2,3]. AN has an estimated incidence of 8/100,000 subjects per year [4], and its
mortality is one of the highest in psychiatric disorders [5]. Despite its devastating physical con-
sequences and strong social impact, its pathophysiology remains unclear [1]. AN patients have
a deceptive self-image, and several studies have shown that the onset of anxiety disorder pre-
cedes the onset of AN pathology in most cases [6,7]. The correlation between anorexia and
anxiety disorders is still to be elucidated.
Animal studies have greatly improved the understanding of AN molecular basis. Particu-
larly, the use of anx/anx mouse strain generated new theories on hypothalamic degeneration
and inflammation that might explain some of the behavioral characteristics of AN [8]. On the
other hand, molecular studies on AN are also providing insight into how diet and nutrition
can alter gene expression [9], which may in turn increases the risk for AN.
Gut microbiota has been demonstrated to play a role in different metabolic functions such
as regulation of weight gain, energy harvest from diet and insulin secretion [10], and to be
highly influenced by diet and life style [11]. Some studies have demonstrated a different micro-
bial composition between obese and normal weight subjects [12,13], but very little has been
explored in patients affected by AN. In addition, recent findings established the presence of a
gut-brain axis [14], and alterations in microbiota composition have been linked to anxiety and
depression [15], frequent in AN patients [16–18]. Indeed, a vicious cycle between microbiota
and psychopathological traits has been suggested, with microbiota alteration participating in
hypersensitivity of the hypothalamus-pituitary-adrenal (HPA) axis in response to stressors
[19], and psychological stress promoting microbial translocation that boosts gut inflammation
[20].
The microbiota produces an array of bioactive metabolic products capable of entering sys-
temic circulation. These metabolic products can have profound effects on host metabolism,
immune function, and gene expression in many organ systems, including the central nervous
system (CNS) [21]. Short chain fatty acids (SCFAs), the main microbial metabolites, are vola-
tile fatty acids produced by bacteria in the large bowel as fermentation products from food
components undigested/unabsorbed in the small intestine. Acetic acid, propionic acid, and
butyric acid are the most abundant, representing 90–95% of SCFAs in colon (ratio of 3:1:1)
[22]. Only a small percentage, about 5%, of SCFAs produced in the colon can be recovered in
feces; butyrate is rapidly used as an energy source for colonocytes, whereas most of acetate and
propionate enter the portal circulation [23]. Butyrate and to a lesser extent propionate and ace-
tate are histone deacetylase (HDAC) inhibitors with potential effects on gene expression in
human cells [24]. Propionate crosses the blood brain barrier and enters the CNS [25] and, like
butyrate, affects various physiological processes such as cell signaling, neurotransmitter syn-
thesis and release, free radical production, and mitochondrial function. From a metabolic
point of view, propionate is the preferred precursor by liver for cholesterol synthesis regulation
and gluconeogenesis[26]. Acetate is the main SCFA in blood, and plays a key metabolic role in
peripheral tissues acting as a substrate for lipogenesis [26].
Data available on microbiota in AN population suggested differences in the microbial ecol-
ogy compared with normal weight individuals. Pfleiderer and colleagues discovered 11 new
bacterial species belonging to Firmicutes, Bacteroidetes and Actinobacteria phyla in AN patients
admitted in the hospital [27], whereas other researchers found an increased abundance of the
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archeon Methanobrevibacter smithii [28]. A lower bacterial diversity characterized AN patients
with greater depression and anxiety [6], and changes in microbial composition and SCFA pro-
files were linked to several gastrointestinal symptoms [29].
Up to date, patients’ management is based on psychotherapy and drug administration to
reduce anxiety or depression but a treatment that targets the causal factors of anorexia nervosa
is still lacking. Due to the spreading of this serious disease, any potential treatment needs to be
carefully considered.
In this context, our study aimed at integrating microbiome data with clinical and psycho-
logical traits in order to elucidate the possible relationship between nutritional status, and the
microbiota-gut-brain axis in Anorexia Nervosa. Indeed, unraveling this link could pave the
way to develop alternative approaches that modulate intestinal microbiota (e.g. probiotics, pre-
biotics), affecting those physiological pathways that are known to be altered in AN.
Materials and methods
Study population and design
We enrolled patients with diagnosis of Anorexia nervosa (AN) referred to the Eating Disorder
Unit of ASST Santi Paolo e Carlo in Milan from January 2016 to June 2016. The study was
reviewed and approved by the local medical ethics committee (Comitato Etico Interaziendale
Milano Area A—protocol number 2015/ST/122). Written informed consent was given by all
enrolled subjects or parent. Inclusion criteria were: a diagnosis of anorexia according to Diag-
nostic and Statistical Manual of Mental Disorders, Fifth Edition criteria [30], female sex, restric-
tive behavior and very low body mass index (BMI, <14 kg/m2) at enrollment. Control group
(CTR), matched for age and sex, was enrolled on a voluntary basis among hospital personnel
and hospital staff’s relatives. Exclusion criteria were: use of antibiotics or probiotics in the
month before the enrolment, celiac disease, irritable bowel syndrome, history of colorectal
cancer, diabetes mellitus, binge eating or purging behavior, recent enteral/parenteral
nutrition.
To avoid biased psychological tests, none of the participants was aware of hypotheses, aims
or the clinical protocol of the study.
Sample collection
Stool samples were collected from all enrolled subjects and stored at -80˚C until use. Blood
samples were taken in the morning under fasting conditions and routinely tested for: cell
blood count, glucose, insulin, cholesterol (total, low density, and high density lipoprotein cho-
lesterol), triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), glu-
tamyltransferase (GGT), alkaline phosphatase (AP), cholinesterase (CHE), sodium, potassium,
total bilirubin, pancreatic lipase, pre-albumin, albumin, transferrin, ferritin, iron binding
capacity (TIBC), indices of renal functions (creatinine, urea), total immunoglobulin A, trans-
glutaminase antibodies, thyroid stimulating hormone level. During blood drawing an addi-
tional sample was collected, processed to obtain serum sample, and subsequently stored at
-80˚C for metabolomic tests.
Dietary evaluation and anthropometric data
Each participant in the study filled in a three-day food record. Food diaries were processed by
dietitians to calculate the average amount of energy and nutrient intake, according to food
composition tables obtained by the Italian aliments composition database for epidemiological
studies (http://www.bda-ieo.it).
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From all subjects we collected anthropometric data: weight, height and body mass index
(BMI) at the time of enrolment. BMI was calculated as ratio between weight, expressed in kilo-
grams, and height, expressed in meters squared [31]. Moreover, each participant’s body com-
position was estimated using bioelectrical impedance analyses (BIA) in order to obtain the
following parameters: fat body mass, fat-free body mass, bone mass, total body water [32].
Psychopathology assessment
The severity of eating disorder and psychopathology tests were assessed by means of the
Symptom Checklist-90 (general psychopathology, [33]), Eating Disorder Inventory 2 (eating
disorder, [34]), State Trait Anxiety Inventory (anxiety disorder, [35]) and Beck Depression
Inventory [depressive symptoms, [36]). Psychologists and psychiatrists (all extensively trained
in the use of the instruments) conducted clinical evaluations.
The Eating Disorder Inventory-2 (EDI-2) is a reliable self-reported questionnaire that
explores typical cognitive and behavioral characteristics of eating disorders. A total of 91
items, answered on a 6-point Likert scale, provide standardized scores on 11 subscales: drive
for thinness, body dissatisfaction, bulimia, effectiveness, perfectionism, interpersonal distrust,
interoceptive awareness, maturity fears, ascetism, impulse regulation, and social insecurity.
The EDI-2 total score (sum of scores in each scale) was used to examine overall eating disorder
severity.
The Symptoms Checklist-90 revised (SCL90) is a self-reported measure used to assess gen-
eral psychopathology. The 90-items questionnaire allows extracting nine primary psychopath-
ological symptom dimensions: (1) somatization; (2) obsession-compulsion; (3) interpersonal
sensitivity; (4) depression; (5) anxiety; (6) hostility; (7) phobic anxiety; (8) paranoid ideation;
and (9) psychoticism. A global index is also present to evaluate the Global Severity Index
(GSI).
The State Trait Anxiety Inventory Scale (STAI, form Y) is composed by two subscales (20
items each): the State Anxiety Scale (STAI-1), and the Trait Anxiety Scale (STAI-2). STAI-1
scale evaluates the current anxiety status, asking how respondent feel “right now”, using items
that measure subjective feelings of apprehension, tension, nervousness, worry, and activation/
arousal of autonomic nervous system. The STAI-2 scale evaluates relatively stable aspects of
“anxiety proneness”, including general states of calmness, confidence, and security.
Beck Depression Inventory-II (BDI-II) is one of the most commonly used self-reported
measure for major depressive disorders [36,37]. The questionnaire is based on 21 items,
divided on 2 subscales: affective and somatic. Each item is rated on a 4-point scale ranging
from 0 to 3. The maximum total score is 63. Total score is used to estimate the level of depres-
sion: 0–13, minimal depression; 14–19, mild depression; 20–28, moderate depression; 29–63,
severe depression.
DNA extraction and sequencing
Total bacterial DNA extraction was performed using the Spin stool DNA kit (Stratec Molecu-
lar, Berlin, Germany), according to the manufacturer’s instructions and amplified by PCR. 25
ng of DNA extracted from each stool sample was utilized to construct a sequencing library.
16S rRNA gene amplicon libraries were performed with a two-step barcoding approach
according to Illumina 16S Metagenomic Sequencing Library Preparation (www.illumina.
com). In the first-step PCR, 16S rRNA genes of all bacteria were amplified as described by
Klindworth et al. [38]. For library preparation, DNA samples coming from first PCR step were
amplified with dual-index primers using Nextera DNA Library Preparation Kit (Illumina, San
Diego, CA, USA). Each sample possessed specific barcode sequences at the front and end of
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the PCR amplicon to discriminate among each other in the pooled library. Both library con-
centration and exact product size were measured using a KAPA Library Quantification Kit
(Kapa Biosystems, Woburn, MA, USA) and an Agilent 2100 Bioanalyzer System (Agilent,
Santa Clara, CA, USA), respectively.
A pooled library (20 nM) and a PhiX control v3 (20 nM) (Illumina) were mixed with 0.2 N
fresh NaOH and HT1 buffer (Illumina) to produce the final concentration at 12 pM each. The
resulting library was mixed with the PhiX control v3 (5%, v/v) (Illumina) and 600 μL loaded
on a MiSeq1 v2 (500 cycle) Reagent cartridge for sequencing. All sequencing procedures
were monitored through the Illumina BaseSpace1 website. Detection of sequencing frag-
ments was performed on Illumina MiSeq platform with a 250PE protocol. Samples were run
in pool of up to 48 plex to obtain an average of 0.15 GBases of sequence data per sample. FastQ
files were generated at the end of the run to perform the quality control. Sequencing reads are
available in NCBI Short Read Archive (SRA, http://www.ncbi.nlm.nih.gov/sra) under ID
PRJNA375065.
Real-time PCR for Methanobrevibcater smithii quantification
Absolute quantification by Real-time PCR was performed using M. smithii DSM-861 as con-
trol strains (DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen). Firstly,
microbial DNA was extracted using Prepman Ultra (Applied Biosystem, USA). Real Time
PCR was carried out using the StepOne Plus instrument (Applied Biosystems) and the
SYBR1 Green chemistry (ThermoScientific, USA). The analysis was performed in a total vol-
ume of 15 μl, and each sample analyzed in triplicate. Standard curve was carried out using five
serial dilutions of control DNA and specific 16S rRNA primers MSfw: 5’-CCGGGTATCTA
ATCCGGTTC-3’ and MSrev: 5’- CTCCCAGGGTAGAGGTGAAA-3’.
The following thermal cycling parameters were used for amplification of DNA: 95˚C for 10
minutes followed by 40 cycles of 15 seconds at 95˚C, 30 seconds at 60˚C, and 30 seconds at 72˚
C. A melting curve analysis was also performed to verify amplicon specificity.
Short chain fatty acid (SCFA) measurement
SCFA concentrations were assessed in accordance with the method proposed by Weaver et al.
[39], modified as follows. Stool (200 mg) were suspended in 1 ml of double distilled water,
homogenized on vortex mixer and, after 30 min, centrifuged (15000 rpm) for 15 min at 10˚C.
Aliquots (500 μl) of supernatant were added with 200 μl 85% orthophosphoric acid, 200 μl 2%
(v/v) sulphuric acid and 100 μl 2-ethyl-butyric acid (Sigma-Aldrich, Italy) 10 mM in HCOOH
12% as internal standard. SCFA were gently extracted for 1 min with 1 ml ethyl-ether/heptane
(1:1 v/v) and centrifuged for 10 min at 3000 rpm. The aqueous phase was frozen and the organic
layer was removed for analysis by a Varian 3400 CX gas liquid chromatograph equipped with a
Varian 8200 CX auto sampler and a HP-FFAP fused-silica capillary column (30 m, 0.53 mm i.d.
with a 1-mm film). Specific chromatography conditions were: gas carrier He with flow 15 ml/
min; splitting 1:10 after 20 seconds injection; injection volume of 1μl. Injector and detector tem-
peratures were 110 and 260˚C, respectively. The initial oven temperature was 60˚C and was
increased by 10˚C min-1 to 110˚ C and then by 5˚C min-1 and held at 200 for 5 min. Quantifi-
cation of the SCFA was obtained through calibration curves of acetic, propionic, iso-butyric,
butyric and iso-valeric acid in concentrations between 0.25 mM and 10 mM (10 mM 2-ethyl-
butyric acid as internal standard).
Serum SCFAs were determined according to the method proposed by Brighenti et al. [40]
modified as follow. Briefly, 1 ml of serum was mixed with 100μl metaphosphoric acid (50%,
v/v) and subsequently centrifuged at 22˚C for 10 min. 500 μl of supernatant were added with
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50μl 2-ethyl-butyric acid (Sigma-Aldrich, Italy) 10 mM in 2% (v/v) sulphuric acid, 200μl 10%
(v/v) sulphuric acid and 1 ml of ethyl ether mixture. Samples were mixed for 2 min and centri-
fuged for 10 min. Samples were stored at -80˚C for one hour, in order to quickly freeze the
aqueous phase and facilitate the recovery of the organic phase containing volatile fatty acids.
The extracts were stored at -20˚C for the following gas-chromatography (GC) analysis.
Specific chromatography conditions were: gas carrier He with flow 22 ml/min; splitting
1:10 after 20 seconds injection; 2μl of injection volume; injector at 200˚C and detector FID at
260˚C. Quantification of the SCFA was obtained through calibration curves of acetic acid in
concentrations between 0.05 mM and 0.5 mM.
Statistical analysis
Statistical analysis was performed using the statistical software R (https://www.r-project.org/)
and Graph Pad Prism (Graph Pad Software, La Jolla, CA). The statistical significance of factors
affecting microbiota composition was evaluated using non-parametric permutational multi-
variate analysis of variance (perMANOVA) and significant clustering of groups was evaluated
with analysis of similarities (ANOSIM). Ordination analysis was performed using redundancy
analysis (RDA) in the vegan package [41] and alpha and beta diversity metrics were also calcu-
lated in the vegan package.
Statistical analysis of cohort-related characteristics comparing AN versus CTR, were per-
formed using Student’s t-test for normally distributed samples and Wilcoxon test for non nor-
mally distributed samples, correlation analysis (Pearson and Spearman correlation coefficient)
and linear regression models. Variables were expressed as mean ± standard deviation (SD),
and for multiple comparisons p-values were adjusted with the False Discovery Rate method
(FDR). A p-value less than or equal to 0.05 was considered statistically significant.
Results
Cohort description
Table 1 shows anthropometric, biochemical and hematological parameters statistically differ-
ent in the two studied groups.
As expected, significant differences were observed in body mass index (BMI) at stool sam-
ple collection time, and body composition. Biochemical tests revealed in AN group higher val-
ues of ALT and AST.
Diet analysis confirmed the characteristic energy restriction in AN diet; compared with
CTR group, AN subjects showed a lower dietary intakes of energy (1,195 Kcal/die ± 264 vs
1,481 Kcal/die ± 209, p = 0.009), total fats (33 g/die ± 11 vs 54 g/die ± 13 p<0.001) and carbo-
hydrates (175 g/die ± 42 vs 204 g/die ± 27, p = 0.049). No significant differences were observed
in fiber and protein intakes.
Psychopathological tests revealed significantly higher levels of depression, anxiety, and eat-
ing disorder psychopathology in AN group compared with controls (Table 2).
Extensive data description can be found in the supplementary S1 Table.
Gut microbiota dysbiosis in anorexia nervosa subjects
Sequencing libraries had a median size of 165,200 sequences (min = 97,010; max = 339,500)
and had a high coverage (median = 99.2% [min = 98.9%; max = 99.7%]). To avoid biases
related to uneven library depth, sequencing libraries were subsampled to a number of reads
smaller than the smallest library (97,000 reads).
Gut microbiota changes in anorexia nervosa subjects
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Table 1. Characteristics of the study population.
AN (n = 15) CTR (n = 15) Reference range§
Weight (Kg)**** 37.0±6.5 59.3±9.3 -
BMI (kg/m2) **** 13.9±2.1 22.1±2.6 -
FM (Kg) **** 1.6±1.1 14.4±7.0 -
FFM (kg) *** 35.2±5.9 44.9±3.7 -
MM (kg) **** 33.3±5.3 42. 6±3.5 -
BM (kcal/die) **** 1,088±137 1,554±732 -
WBC count (103/μL)* 4.5±1.8 6.1±1.7 3.6–9.2
CHE (U/L)* 5,960±1388 6,886±1288 4,650–10,440
Insulin (μU/ml) **** 3.4±1.7 7.7±2.6 0–25
ALT (U/L) *** 44.5±18.3 25.4±7.7 9.0–52.0
AST (U/L) *** 35.3±11.2 22.1±4.2 14.0–36.0
Data are expressed as mean ± standard deviation. AN, anorexia nervosa; CTR, control group; BMI, body
mass index; FM, fat mass; FFM, free fat mass; MM, muscle mass; BM, basal metabolism; WBC count, white
blood cells count; CHE, cholinesterase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
**** p <0.0001
***p <0.001
*p 0.05.
§Reference range for biochemical parameters.
https://doi.org/10.1371/journal.pone.0179739.t001
Table 2. Raw scores for psychopathological assessment.
AN (n = 15) CTR (n = 15) p-value
EDI-2 Drive for thinness 11.4±7.4 0.9±2.4 <0.0001
Bulimia 3.2±4.5 1.2±2.6 n.s.
Body dissatisfaction 10.6±5.4 4.4±5.1 0.002
Effectiveness 9±8.1 0.6±0.9 <0.0001
Perfectionism 4.8±3.5 2±1.8 0.013
Interpersonal distrust 5.2±4.7 0.8±1.2 0.005
Ineroceptive 8.0±7.6 0.6±2.1 <0.001
Awarness 7.5±4.8 2.4±2.2 0.001
Maturity fears 6.8±5.3 1.8±1.1 0.003
Impulse regulation 4.7±5.5 0.6±1.3 0.004
Social insecurity 7.1±6.8 1.2±1.8 0.001
SCL90 Somatization 0.8±0.5 0.4±0.4 n.s.
Obsession-compulsion 1.2±0.7 0.4±0.3 0.002
Interpersonal 1.1±0.8 0.4±0.4 0.009
Depression 1.6±1.0 0.4±0.3 <0.001
Anxiety 1.2±0.8 0.4±0.3 0.004
Hostility 0.9±0.8 0.3±0.4 0.020
Phobic anxiety 0.6±0.8 0.1±0.2 0.003
Paranoid ideation 1.1±0.8 0.4±0.5 0.021
Psychoticism 0.7±0.5 0.1±0.2 <0.001
Sleeping 1.7±1.2 0.4±0.71 0.001
Global index 1.1±0.6 0.4±0.2 <0.001
STAI-Y State anxiety 47.4±14.1 33.1±5.4 0.001
Trait anxiety 53.6±11.1 34.1±5.4 <0.0001
BDI Total score 20.4±11.9 2.5±2.6 <0.0001
Data are expressed means ± standard deviation. AN, anorexia nervosa; CTR, control group; n.s., not significant; EDI-2, Eating Disorder Index-2; SCL90,
Symptoms Checklist-90 revised; STAI-Y, State Trait Anxiety Inventory, form Y; BDI, Beck Depression Inventory.
https://doi.org/10.1371/journal.pone.0179739.t002
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Bacterial composition within each sample (α-diversity) and between CTR and AN groups
(β-diversity) was measured by using operational taxonomic unit (OTU)-based methods. All
metrics estimates were not statistically significant.
Gut microbiota composition at phylum and family level is reported in Fig 1 for the AN and
CTR groups.
At phylum level, the predominant bacterial taxa were Firmicutes and Bacteroidetes followed
by Proteobacteria, Actinobacteria and Verrucomicrobia (Fig 1A). The most abundant families
were Bacteroidaceae, Ruminococcaceae, Lachnospiracea, Veillonellaceae, Enterobacteriaceae,
Rikenellaceae, Porphyromonadaceae, Verrumicrobiaceae, Bifidobacteriaceae, and Prevotellaceae,
(Fig 1B). The most abundant genera were Bacteroides, Ruminococcus, Dialister, Faecalibacter-
ium, Akkermansia, Parabacteroides, Bifidobacterium, and Prevotella (S1 Fig).
Significant differences in taxa between AN and CTR are reported in Table 3.
The composition of the intestinal microbiota was significantly affected by anorexia status at
every taxonomic level, as determined by non-parametric multivariate analysis of variance (per-
MANOVA; p<0.05 for all levels). Redundancy analysis (RDA) showed that samples were dis-
tinctly grouped (Fig 2).
This grouping was confirmed at OTUs level by the analysis of similarity (ANOSIM) test,
which evaluates significance of sample grouping (p = 0.03).
Moreover, a significant increase of Gram-negative bacteria was observed in AN participants
compared with CTR (p = 0.03).
Archeabacteria, with the main genus Methanobrevibacter, were detected in 30% of AN and
CTR subjects. Quantification of Methanobrevibacter smithii using real-time PCR has shown a
higher average of genome copy number of the archeon in AN group (p = 0.0259).
Fecal and systemic microbial metabolites
Fecal concentrations of total SCFAs, butyrate and propionate were significantly (p<0.05)
decreased in AN samples, while acetate, iso-valerate and iso-butyrate were not different
between groups (Table 4).
Fig 1. Relative abundance of common microbial taxa. Bar charts showing the relative abundance of the most
represented microbial taxa, defined as having a mean relative abundance of >1%, in stool samples of anorexia nervosa (AN,
n = 15) and control (CTR, n = 15) groups. Phylum-level (a) and family-level (b) taxon profiles are shown.
https://doi.org/10.1371/journal.pone.0179739.g001
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Table 3. Taxa significantly increased (+) or decreased (-) in abundance in anorexia nervosa subjects.
Taxonomic level Taxa Relative abundance AN p-value
CTR AN
Phylum Firmicutes
Proteobacteria
55.2±12.1
4.7±5.3
45.9±8.8
8.9±8.9
-
+
0.041
0.031
Family Ruminococcaceae 25.6±13.6 16.6±8.0 - 0.033
Enterobacteriaceae 2.7±4.9 7.6±9.2 + 0.047
Genus Ruminococcus 4.8±3.8 2.2±2.4 - 0.019
Roseburia 2.3±2.2 0.8±0.9 - 0.037
Clostridium 1.4±3.6 0.2±0.2 - 0.031
Data are expressed means ± standard deviation. AN, anorexia nervosa; CTR, control group.
https://doi.org/10.1371/journal.pone.0179739.t003
Fig 2. Redundancy analysis (RDA) of gut microbiota. RDA shows a separation between anorexia nervosa (AN, red dots) and
control (CTR, blue dots) subjects.
https://doi.org/10.1371/journal.pone.0179739.g002
Gut microbiota changes in anorexia nervosa subjects
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Acetate was the only SCFA detected in serum, with no significant differences in the two
experimental groups (AN; 0.037 μM ± 0.02 (mean ±SD), CTR; 0.042 μM ±0.02). No significant
relationship was observed between systemic and fecal acetate.
Complex interplay between psychopathology tests, clinical status and
microbiota profiles
Correlation tests were carried out in order to find possible associations between gut microbiota
composition and cohort characteristics. The correlation analysis performed at OTUs level
revealed two OTUs related to insulin and BMI, respectively. OTU 3485 (100% sequence simi-
larity with Accession Number NR_042007.1 Roseburia inulinivorans) was positively correlated
with insulin values (p = 0.0397), while the OTU 5247 (99% sequence similarity with Accession
Number NR_112945.1 Bacteroides uniformis) was negatively related with BMI (p = 0.0194).
Other biochemical parameters were not significantly associated with gut microbiota
composition.
PerMANOVA analysis confirmed the significant correlations between gut microbiota,
insulin and BMI; insulin correlated with gut communities at OTUs level (p = 0.002), and BMI
at every taxonomic level (p< 0.05).
BMI was also positively associated with SCFA concentration (total SCFAs, p = 0.0125; buty-
rate, p = 0.0035; propionate, p = 0.0137; and iso-Butyrate, p = 0.0282).
Association between BMI, insulin and propionate was revealed by RDA analysis (Fig 3).
In a multivariate analysis, we found BMI to be negatively associated (p<0.05) with the fol-
lowing psychopathologic parameters: obsession-compulsion, depression, and anxiety (SCL-90
and BDI inventory).
We then investigated possible correlation between microbiome and psychological traits.
Statistical analysis revealed a negative correlation only between BDI depression score and
Clostridium spp. (p = 0.0089), whereas fecal butyrate concentration inversely correlated with
depression (p = 0.0379) and anxiety (p = 0.0206) scores.
Discussion
Our study described clinical and anthropometric parameters, psychological status, microbiota
and SCFA profiles in anorexia nervosa subjects, integrating the current literature on gut dys-
biosis in AN [1,28,29,42].
Anorexia status was characterized by an altered intestinal microbiota composition, with
unbalanced Gram positive/Gram negative relative abundance. The microbiota of AN subjects
was enriched in Bacteroidetes and depleted in Firmicutes, thus showing an opposite trend
Table 4. Fecal SCFA concentrations in anorexia nervosa subjects and healthy control group.
Fecal SCFA (mg/g feces)
AN CTR p-value
Total SCFAs 4.7±2.1 6.8±1.6 0.041
Acetate 2.7±1.5 3.8±1.1 n.s.
Butyrate 0.7±0.4 1.1±0.5 0.045
Propionate 0.8±0.4 1.1±0.3 0.028
Iso-valerate 0.4±0.2 0.5±0.2 n.s.
Iso-butyrate 0.2±0.1 0.2±0.1 n.s.
Data are means ± standard deviation. AN, anorexia nervosa; CTR, control group; n.s., not significant
https://doi.org/10.1371/journal.pone.0179739.t004
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 10 / 17
compared with what described in obese subjects [12,20]. In particular, the relative abundance
of the carbohydrate-fermenter Ruminococcus, Roseburia and Clostridium genera, belonging to
Firmicutes, was decreased in AN. This is in agreement with previous data [1,29], and supports
the significantly lower fecal butyrate concetration assessed in AN subjects. Roseburia spp.,
such as R. faecis, R. inulinivorans, R. intestinalis, and R. hominis, are important butyrate-pro-
ducing species. Roseburia intestinalis is a mucosa-associated species that increases the bioavail-
ability of butyrate as energy source for colonocytes. R. intestinalis has been suggested to be also
a polyamine producer, thus essential for the maintenance and function of gastrointestinal epi-
thelium. A reduced polyamine production could alter the structure of the epithelial layer,
Fig 3. Distance-based redundancy analysis (db-RDA). Db-RDA plot shows correlations between gut microbiota composition and body mass index
(BMI), insulin, propionate and butyrate. Only significant variables are represented (p>0.05, Permanova analysis). Arrows in the db-RDA biplot denote the
magnitudes and directions of the variable effects. Controls are represented by blue dots and anorexic subjects by red dots.
https://doi.org/10.1371/journal.pone.0179739.g003
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affecting the survival of adherent microbes that in turn could have a significant effect on
energy harvest from food [43].
Decreased Roseburia spp. abundance has been also found in patients with infammatory
bowel diseases [44]. Altered intestinal permeability [45] and low-grade inflammation [46] has
been also shown in animal models of AN, suggesting a putative role in the pathophysiology of
AN.
Both pro-inflammatory cytokines, mainly IL-1β and TNF-α [47], and mucosal microbes
could affect feeding behavior and satiety [48]; in particular, microbially derived SCFAs can
promote the release by enteroendocrine cells of peptide YY (PYY) and glucagon-like peptide
(GLP) that in turn regulate appetite and insulin secretion.
The Gram-negative Proteobacteria, were also enriched in AN microbial community, and
Enterobacteriaceae were overrepresented compared with control subjects. Enterbacteriaceae
have been associated to gut inflammation that in turn favors bacterial translocation, promoting
systemic inflammation [49].
A recent report suggested a new role for Enterobacteriaceae in eating disorders; this family,
and in particular Escherichia coli species, can produce, amongst other metabolites, an anorexi-
genic and anxiogenic protein, the caseinolyitic protease b (ClpB) [50]. ClpB seems to interfere
with α-melanocyte-stimulating hormone involved in satiety and anxiety signaling [51]. Breton
and colleagues found an association between eating disorders and ClpB [50]. In agreement
with this observation, the increased abundance of Gram negative bacteria might be linked to a
higher production of neuropeptide ClpB, which could mediate in the communication between
the gut-brain axis in AN subjects.
Moreover, AN microbial communities were enriched in Methanobrevibacter smithii. This
Archea species is able to transform hydrogen in methane, and allows extracting extra calories
from nutrients [28]. However, M.smithii has been found in the microbiota of patients suffering
of obesity, non-alcoholic fatty liver disease, and cirrhosis [52]. Liver dysfunction is a common
feature in AN and an increase in liver enzymes has been previously described [53,54] and con-
firmed in this study.
Changes in the abundance of microbial communities lead to changes in the quantity/quality
of microbial metabolites. Indeed, reduction in Firmicutes is in line with the lower fecal butyrate
concentration in AN group. Interestingly, butyrate was negatively correlated with depression
and anxiety. Sodium butyrate has been demonstrated to elicit antidepressant effects on murine
brain. When injected systemically, sodium butyrate induced a short-lasting, transient acetyla-
tion of histones in frontal cortex and hippocampus, in conjunction with dynamic changes in
expression of brain-derived neurotrophic factor (BDNF), thereby resulting in an antidepres-
sant-like behavioral response [55].
Faecal propionate was also significantly reduced in AN subjects. A depletion in Roseburia
species, and in particular of Roseburia inulinivorans, could result in a decrease production of
propionate [56]. R. inulinivorans produces propionate from fucose via propanediol, and buty-
rate when grown in the presence of glucose [57]. Interestingly, our data showed a significant
direct correlation between this species and insulin concentration, and insulin levels in AN
group were significantly lower than healthy controls. This “profile” suggests a possible link
between Roseburia species and insulin metabolism. A reduced insulin is a phenomenon well
documented in literature [58] that helps AN subjects to preserve euglycemia.
Propionate has beneficial effects on β-cell function, potentiating glucose-stimulated insulin
release and maintaining β-cell mass through inhibition of apoptosis [59]. On the other hand,
propionate has been shown to inhibit adipogenesis [60], and the link might be represented by
reduced insulin levels.
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Other biochemical parameters were found altered in AN group; white blood cell count, and
cholinesterase level were reduced, whereas transaminase were increased. These alterations
have been already reported in literature [3,61] and represent both a clinical adaptation and a
marker of the effects of starvation and malnutrition.
Anorexic patients, as expected, showed reduced BMI, fat mass, and free fat mass if com-
pared with healthy subjects. BMI is considered a severity index in AN patients, especially to
define enduring AN [62]. Despite nutritional and psychological support, all enrolled subjects
failed to recover BMI or stabilize weight gain, leading to a fluctuation in BMI as previously
reported [63].
BMI resulted a good predictive value for dysbiosis level. The correlation analysis revealed
that Bacteroides uniformis was negatively correlated with BMI, in agreement with our recent
study on obese children in which members of the Bacteroidetes phylum were generally good
predictors of BMI [20].
BMI was also inversely correlated with all psychological tests, and in particular with obses-
sion-compulsion, depression, and anxiety. Longitudinal studies on AN cohorts suggested that
weight gain during renourishment, leads to improvements of psychological symptoms [6].
In this study, we observed that fecal butyrate concentration and Clostridium spp. negatively
correlate with anxiety and depression scores. This result is consistent with Bailey et al. [64]
who demonstrated that exposure of mice to a social disruption stressor results in a significant
decreases in Clostridium spp. abundance.
In order to understand whether short-chain fatty acids could exert a direct effect on gut-
brain axis by entering the systemic circulation, we evaluated their concentrations in plasma.
Acetate was the only metabolite found in our samples, whereas propionate and butyrate were
undetectable. Indeed, acetate is the most abundant metabolite produced and released systemi-
cally. In healthy subjects the molar ratio of acetate:propionate:butyrate in peripheral blood is
approximately 80:10:10, representing 1/1000th of the concentration present in the large intes-
tine [65].
Systemic acetate can cross the blood–brain barrier and has been demonstrated to directly
suppress appetite through central hypothalamic mechanisms in mice [66]; however no signifi-
cant differences were observed in plasma acetate concentration between the two studied
groups.
It should be considered that SCFAs could affect the gut-brain axis also through a modula-
tion of the enteric nervous systems, by stimulating gut hormones and cytokine release or
directly via afferent neural pathways [67].
In conclusion, in the present study a significant dysbiosis was observed in AN patients, with
specific changes in microbial genera that might participate in AN pathophysiology. More stud-
ies will be needed for dissecting if the restricted diet consumed by AN patients, starving the
microbiota, is responsible for the observed alterations.
The finding of reduced fecal butyrate and butyrate-producing genera, such as Roseburia
spp., indicates microbial modulation as a possible tool to implement current AN treatment.
Indeed, it has been shown both in humans and in mice that probiotic supplementation with
lactobacilli and bifidobacteria, by stimulating a cross-feeding mechanism, increases Roseburia
abundance and butyrate production [68]. Moreover, pre- and probiotic administration could
represent a feasible intervention for AN patients because of its extremely low calories or calo-
rie-free content, improving recovery rates.
Taken together our data highlight the close relationship between microbial community,
peculiar diet and psychiatric disorders, opening important questions to be addressed for ascer-
taining causes/consequences of observed dysbiosis in AN.
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 13 / 17
Supporting information
S1 Table. Cohort description (demographic, anthropometric, biochemical, and psycholog-
ical data), diet and short-chain fatty acids concentrations.
(XLSX)
S1 Fig. Relative abundance of most represented microbial genera. Bar charts showing the
relative abundance of the most represented genera, defined as having a mean relative abun-
dance of>1%, in stool samples of anorexia nervosa (AN, n = 15) and control (CTR, n = 15)
groups.
(EPS)
Acknowledgments
This research was supported by Università degli Studi di Milano.
Author Contributions
Conceptualization: Francesca Borgo, Antonio E. Pontiroli, Giulia Morace, Elisa Borghi.
Data curation: Francesca Borgo, Alessandra Riva.
Formal analysis: Francesca Borgo, Alessandra Riva.
Funding acquisition: Antonio E. Pontiroli, Elisa Borghi.
Investigation: Francesca Borgo, Alberto Benetti, Maria Cristina Casiraghi, Sara Bertelli, Stefa-
nia Garbossa, Simona Anselmetti.
Project administration: Antonio E. Pontiroli, Elisa Borghi.
Resources: Alberto Benetti, Maria Cristina Casiraghi, Sara Bertelli, Simona Anselmetti, Silvio
Scarone, Antonio E. Pontiroli, Elisa Borghi.
Supervision: Silvio Scarone, Antonio E. Pontiroli, Elisa Borghi.
Validation: Antonio E. Pontiroli, Giulia Morace, Elisa Borghi.
Visualization: Francesca Borgo, Alessandra Riva, Elisa Borghi.
Writing – original draft: Francesca Borgo, Alessandra Riva.
Writing – review & editing: Antonio E. Pontiroli, Giulia Morace, Elisa Borghi.
References
1. Morita C, Tsuji H, Hata T, Gondo M, Takakura S, Kawai K, et al. Gut Dysbiosis in Patients with Anorexia
Nervosa. PLoS One. 2015; 10(12):e0145274. https://doi.org/10.1371/journal.pone.0145274 PMID:
26682545
2. Klump KL, Bulik CM, Kaye WH, Treasure J, Tyson E. Academy for eating disorders position paper: Eat-
ing disorders are serious mental illnesses. International Journal of Eating Disorders. 2009; 42(2):97–
103. https://doi.org/10.1002/eat.20589 PMID: 18951455
3. Mehler PS, Brown C. Anorexia nervosa—medical complications. J Eat Disord.2015; 3(1):11.
4. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr
Opin Psychiatry. 2006; 19(4):389–394. https://doi.org/10.1097/01.yco.0000228759.95237.78 PMID:
16721169
5. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry. 1995; 152(7):1073–1074. https://doi.org/
10.1176/ajp.152.7.1073 PMID: 7793446
6. Kleiman SC, Watson HJ, Bulik-Sullivan EC, Huh EY, Tarantino LM, Bulik CM, et al. The intestinal micro-
biota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 14 / 17
eating disorder psychopathology. Psychosom Med. 2015; 77(9):969–981. https://doi.org/10.1097/PSY.
0000000000000247 PMID: 26428446
7. Swinbourne JM, Touyz SW. The co-morbidity of eating disorders and anxiety disorders: a review. Eur
Eat Disord Rev [Internet]. 2007; 15(4):253–274. https://doi.org/10.1002/erv.784 PMID: 17676696
8. Mercader JM, Gonza´lez JR, Lozano JJ, Bak M, Kauppinen S, Sumoy L, et al. Aberrant brain microRNA
target and miRISC gene expression in the anx/anx anorexia mouse model. Gene. 2012; 497(2):181–
190. https://doi.org/10.1016/j.gene.2012.01.057 PMID: 22310387
9. Kaelin WG, McKnight SL. Influence of metabolism on epigenetics and disease. Cell. 2013; 153(1):56–
69. https://doi.org/10.1016/j.cell.2013.03.004 PMID: 23540690
10. Tremaroli V, Ba¨ckhed F. Functional interactions between the gut microbiota and host metabolism.
Nature. 2012; 489(7415):242–249. https://doi.org/10.1038/nature11552 PMID: 22972297
11. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the
human gut microbiota. Nature. 2012; 489(7415):220–230. https://doi.org/10.1038/nature11550 PMID:
22972295
12. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial
ecology. Proc Natl Acad Sci U S A. 2005; 102(31):11070–11075. https://doi.org/10.1073/pnas.
0504978102 PMID: 16033867
13. Turnbaugh PJ, Ley RE, Mahowald M a, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut
microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027–1031. https://
doi.org/10.1038/nature05414 PMID: 17183312
14. Cryan JF, O’Mahony S. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol
Motil. 2011; 23(3):187–192. https://doi.org/10.1111/j.1365-2982.2010.01664.x PMID: 21303428
15. Foster JA, Neufeld K-AM. Gut–brain axis: how the microbiome influences anxiety and depression.
Trends Neurosci. 2013; 36(5):305–312. https://doi.org/10.1016/j.tins.2013.01.005 PMID: 23384445
16. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbidity of anxiety disorders with
anorexia and bulimia nervosa. Am J Psychiatry. 2004; 161(12):2215–2221. https://doi.org/10.1176/
appi.ajp.161.12.2215 PMID: 15569892
17. Godart NT, Flament M, Perdereau F, Jeammet P. Comorbidity between eating disorders and anxiety
disorders: a review. Int J Eat Disord. 2002; 32(3):253–270. https://doi.org/10.1002/eat.10096 PMID:
12210640
18. Fernandez-Aranda F, Poyastro Pinheiro A, Tozzi F, La Via M, Thornton LM, Plotnicov KH, et al. Symp-
tom profile of major depressive disorder in women with eating disorders. Aust N Z J Psychiatry. 2007;
41(1):24–31. https://doi.org/10.1080/00048670601057718 PMID: 17464678
19. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu X-NX, et al. Postnatal microbial colonization pro-
grams the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004; 558(Pt
1):263–275. https://doi.org/10.1113/jphysiol.2004.063388 PMID: 15133062
20. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: A review. Brain
Behav Immun. 2017.
21. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic
product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in
adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res. 2011; 217(1):47–54. https://
doi.org/10.1016/j.bbr.2010.10.005 PMID: 20937326
22. Rı´os-Covia´n D, Ruas-Madiedo P, Margolles A, Gueimonde M, De los Reyes-Gavila´n CG, Salazar N.
Intestinal short chain fatty acids and their link with diet and human health. Frontiers in Microbiology.
2016; 7:185. https://doi.org/10.3389/fmicb.2016.00185 PMID: 26925050
23. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch
and nonstarch polysaccharides. Physiol Rev. 2001; 81(3):1031–1064. PMID: 11427691
24. Waldecker M, Kautenburger T, Daumann H, Veeriah S, Will F, Dietrich H, et al. Histone-deacetylase
inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts.
Nutrition. 2008; 24(4):366–374. https://doi.org/10.1016/j.nut.2007.12.013 PMID: 18262392
25. Harrison IF, Dexter DT. Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkin-
son’s disease? Pharmacol Ther. 2013; 140(1):34–52. https://doi.org/10.1016/j.pharmthera.2013.05.
010 PMID: 23711791
26. Puertollano E, Kolida S, Yaqoob P. Biological significance of short-chain fatty acid metabolism by the
intestinal microbiome. Curr Opin Clin Nutr Metab Care. 2014; 17(2):139–144. https://doi.org/10.1097/
MCO.0000000000000025 PMID: 24389673
27. Pfleiderer A, Lagier J-C, Armougom F, Robert C, Vialettes B, Raoult D. Culturomics identified 11 new
bacterial species from a single anorexia nervosa stool sample. Eur J Clin Microbiol Infect Dis. 2013; 32
(11):1471–1481. https://doi.org/10.1007/s10096-013-1900-2 PMID: 23728738
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 15 / 17
28. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut
microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients.
PLoS One. 2009; 4(9):e7125. https://doi.org/10.1371/journal.pone.0007125 PMID: 19774074
29. Mack I, Cuntz U, Gramer C, Niedermaier S, Pohl C, Schwiertz A, et al. Weight gain in anorexia nervosa
does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal com-
plaints. Sci Rep. 2016; 6(January):26752. https://doi.org/10.1038/srep26752 PMID: 27229737
30. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
31. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age-and
sex-specific prediction formulas. Br J Nutr. 1991; 65(2):105–114. PMID: 2043597
32. Strain GW, Wang J, Gagner M, Pomp A, Inabnet WB, Heymsfield SB. Bioimpedance for severe obesity:
comparing research methods for total body water and resting energy expenditure. Obesity. 2008; 16
(8):1953–1956. https://doi.org/10.1038/oby.2008.321 PMID: 18551107
33. Derogatis LR, Lazarus L. SCL-90—R, Brief Symptom Inventory, and matching clinical rating scales. In:
The use of psychological testing for treatment planning and outcome assessment. 1994. pp. 217–248.
34. Garner DM, Olmstead MP, Polivy J. Development and validation of a multidimensional eating disorder
inventory for anorexia nervosa and bulimia. Int J Eat Disord. 1983; 2:15–34.
35. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety
Inventory (Form Y). Manual for the statetrait anxiety inventory STAI. 1983. pp. 4–6
36. Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. San Antonio, TX Psychol
Corp. 1996. pp. 1–82.
37. Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck Depression Inventory-II in clinically
depressed outpatients. J Clin Psychol. 1999; 55(1):117–128. PMID: 10100838
38. Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribo-
somal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies.
Nucleic Acids Res. 2013; 41(1): e1. https://doi.org/10.1093/nar/gks808 PMID: 22933715
39. Weaver GA, Tangel CT, Krause JA, Parfitt MM, Jenkins PL, Rader JM, et al. Acarbose enhances
human colonic butyrate production. J Nutr. 1997; 127(5):717–723. PMID: 9164992
40. Brighenti F, Ciappellano S, Vuksan V, Rao A V, Wolever TMS, Jenkins A, et al. Is colonic fermentation
minimized by increasing meal frequency? Eur J Clin Nutr. 1991; 45(4):221–226. PMID: 1879386
41. Oksanen J, Kindt R, Legendre P, Hara BO, Simpson GL, Solymos P, et al. vegan: Community Ecology
Package. R package version 1.17–3. October. 2010;10(1):2008.
42. Million M, Thuny F, Angelakis E, Casalta JP, Giorgi R, Habib G, et al. Lactobacillus reuteri and Escheri-
chia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment.
Nutr Diabetes. 2013; 3:e87. https://doi.org/10.1038/nutd.2013.28 PMID: 24018615
43. Seiler N, Raul F. Polyamines and the intestinal tract. Crit Rev Clin Lab Sci. 2007; 44(4):365–411.
https://doi.org/10.1080/10408360701250016 PMID: 17558654
44. Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, et al. Interplay of host genetics and
gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut [Inter-
net]. 2016;gutjnl-2016-312135. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27802154
45. Je´sus P, Ouelaa W, Franc¸ois M, Riachy L, Gue´rin C, Aziz M, et al. Alteration of intestinal barrier function
during activity-based anorexia in mice. Clin Nutr. 2014; 33(6):1046–1053. https://doi.org/10.1016/j.clnu.
2013.11.006 PMID: 24290874
46. Belmonte L, Achamrah N, Nobis S, Gue´rin C, Riou G, Boˆle-Feysot C, et al. A role for intestinal TLR4-
driven inflammatory response during activity-based anorexia. Sci Rep. 2016; 6:35813. https://doi.org/
10.1038/srep35813 PMID: 27779218
47. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and
depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9(1): 46–56.
https://doi.org/10.1038/nrn2297 PMID: 18073775
48. Alcock J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evo-
lutionary pressures and potential mechanisms. BioEssays. 2014; 36(10):940–9. https://doi.org/10.
1002/bies.201400071 PMID: 25103109
49. Winter SE, Ba¨umler AJ. Dysbiosis in the inflamed intestine: Chance favors the prepared microbe. Gut
Microbes. 2014; 5(1):71–73. https://doi.org/10.4161/gmic.27129 PMID: 24637596
50. Breton J, Legrand R, Akkermann K, Ja¨rv A, Harro J, De´chelotte P, et al. Elevated plasma concentra-
tions of bacterial ClpB protein in patients with eating disorders. Int J Eat Disord. 2016; 49(8):805–8.
https://doi.org/10.1002/eat.22531 PMID: 27038326
51. Adan RAH, Vink T. Drug target discovery by pharmacogenetics: mutations in the melanocortin system
and eating disorders. Eur Neuropsychopharmacol. 2001; 11(6):483–490. PMID: 11704425
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 16 / 17
52. Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepato-
biliary Pancreat Dis Int. 2015; 14(6):572–581. PMID: 26663004
53. Goh KHR, Lee EL. Prevalence of abnormal liver function tests and comorbid psychiatric disorders
among patients with anorexia nervosa and eating disorders not otherwise specified in the anorexia ner-
vosa DSM-IV criteria. Singapore Med J. 2015; 56(9):488–492. https://doi.org/10.11622/smedj.2015132
PMID: 26451050
54. Rosen E, Sabel AL, Brinton JT, Catanach B, Gaudiani JL, Mehler PS. Liver dysfunction in patients with
severe anorexia nervosa. Int J Eat Disord. 2015;151–158.
55. Schroeder FA, Lin CL, Crusio WE, Akbarian S. Antidepressant-like effects of the histone deacetylase
inhibitor, sodium butyrate, in the mouse. BiolPsychiatry. 2007; 62(1):55–64.
56. Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate-producing bacteria revealed
by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol. 2010; 12(2):304–314.
https://doi.org/10.1111/j.1462-2920.2009.02066.x PMID: 19807780
57. Scott KP, Martin JC, Campbell G, Mayer CD, Flint HJ. Whole-genome transcription profiling reveals
genes up-regulated by growth on fucose in the human gut bacterium “Roseburia inulinivorans.” J Bac-
teriol. 2006; 188(12):4340–4349. https://doi.org/10.1128/JB.00137-06 PMID: 16740940
58. Misra M, Klibanski A. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol. 2014;
2(7):581–592. https://doi.org/10.1016/S2213-8587(13)70180-3 PMID: 24731664
59. Pingitore A, Chambers E, Wallis G, Frost G, Persaud S. The diet-derived short chain fatty acid propio-
nate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro.
Diabetes Obes Metab. 2017; 19(2):257–265. https://doi.org/10.1111/dom.12811 PMID: 27761989
60. Arora T, Sharma R, Frost G. Propionate. Anti-obesity and satiety enhancing factor? Appetite. 2011; 56
(2):511–515. https://doi.org/10.1016/j.appet.2011.01.016 PMID: 21255628
61. Montagnese C, Scalfi L, Signorini A, De Filippo E, Pasanisi F, Contaldo F. Cholinesterase and other
serum liver enzymes in underweight outpatients with eating disorders. Int J Eat Disord. 2007; 40
(8):746–50. https://doi.org/10.1002/eat.20432 PMID: 17610252
62. Wildes JE, Forbush KT, Hagan KE, Marcus MD, Attia E, Gianini LM, Wu W.Characterizing severe and
enduring anorexia nervosa: An empirical approach. Int J Eat Disord. 2017; 50(4):389–397. https://doi.
org/10.1002/eat.22651 PMID: 27991694
63. Kaplan AS, Walsh BT, Olmsted M, Attia E, Carter JC, Devlin MJ, et al. The slippery slope: prediction of
successful weight maintenance in anorexia nervosa. Psychol Med. 2009; 39(6):1037–45. https://doi.
org/10.1017/S003329170800442X PMID: 18845008
64. Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters
the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation. Brain
Behav Immun. 2011; 25(3):397–407. https://doi.org/10.1016/j.bbi.2010.10.023 PMID: 21040780
65. Ktsoyan ZA, Mkrtchyan MS, Zakharyan MK, Mnatsakanyan AA, Arakelova KA, Gevorgyan ZU, et al.
Systemic concentrations of short chain fatty acids are elevated in salmonellosis and exacerbation of
familial mediterranean fever. Front Microbiol. 2016; 7:776. https://doi.org/10.3389/fmicb.2016.00776
PMID: 27252692
66. Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, et al. The short-chain fatty acid
acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014; 5:3611. https://doi.
org/10.1038/ncomms4611 PMID: 24781306
67. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev
Microbiol. 2012; 10(11):735–742. https://doi.org/10.1038/nrmicro2876 PMID: 23000955
68. Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V, Fong SB, Bonnaure-Mallet M, Jolivet-
Gougeon A. Roseburia spp.: a marker of health? Future Microbiol. 2017; 12:157–170. https://doi.org/
10.2217/fmb-2016-0130 PMID: 28139139
Gut microbiota changes in anorexia nervosa subjects
PLOS ONE | https://doi.org/10.1371/journal.pone.0179739 June 21, 2017 17 / 17
